International Certifications Novell Pharmaceutical Laboratories holds GMP approval from Europe, Australia, South Africa, and Gulf countries, demonstrating a strong compliance with international quality standards which can facilitate entry into global markets and partnerships.

Expanding Market Presence With offices and marketing teams in the Philippines, Thailand, and Vietnam, Novell is actively expanding its regional footprint, offering opportunities for regional distributors and healthcare providers to collaborate on new product distribution.

Diverse Product Portfolio The company's focus on developing high-value, quality pharmaceutical products to provide cost-effective alternatives positions it well for partnerships in both innovative and generic medicine segments targeting emerging markets.

Regulatory Leadership Being the first Indonesian company to obtain EU drug approval highlights Novell’s regulatory expertise and credibility, making it an attractive partner for international companies seeking efficient pathways to market access.

Growth and Revenue With revenues between $250M and $500M and a sizable workforce of over 1,000 employees, Novell offers substantial market presence and capacity for scaling supply chain collaborations and joint ventures.